Skip to main content

Bill Gates doesn’t expect a coronavirus vaccine by the end of the year

Microsoft co-founder Bill Gates said he doesn’t expect a coronavirus vaccine to become available by the end of the year, bucking President Donald Trump’s previous statements that one would be ready by the November election.

“None of the vaccines are likely to seek approval in the U.S. before the end of October,” said Gates in a recently published interview with CNBC. “I do think once you get into, say, December or January, the chances are that at least two or three will (seek approval) — if the effectiveness is there.”

“And so we have these phase three trials that are going on. The only vaccine that if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer,” he continued.

Gates and his wife Melinda head the world’s largest private foundation and have been monitoring the coronavirus pandemic since the beginning of this year — before the disease made its way to the U.S. The Bill and Melinda Gates Foundation partnered with, and funded, several drug makers in March, including Pfizer. Since the beginning of the pandemic, Gates has poured billions of dollars into at-home test kits and vaccine trials across the world, while also being very critical of the president for his response to the virus.

Pfizer CEO Albert Bourla told CNBC that if a vaccine is approved, the company will be prepared to hand out “hundreds of thousands of doses.”

However, when President Trump announced a vaccine for the virus that has killed nearly 195,000 Americans to be ready by election day, many critics and experts wondered if safety protocols were rushed in turn for political promises made by the current administration.

In a tweet, the president wrote, “The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics […] Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”

In the CNBC report, Gates doubted that a large pharmaceutical manufacturer would seek a vaccine approval without proof of large-scale effectiveness, citing a letter signed by nine of the top drug makers pledging to follow the U.S. Food and Drug Administration procedures.

“We also have to go through all the safety steps so that people feel like they want to participate in taking this vaccine,” said Gates.

Editors' Recommendations

Meira Gebel
Meira Gebel is a freelance reporter based in Portland. She writes about tech, social media, and internet culture for Digital…
Moderna says early coronavirus vaccine results are promising
Cambridge Biotech Moderna Leads in Race For Coronavirus Vaccine

Biotechnology company Moderna has announced the first results from its Phase 1 trial of a vaccine for the coronavirus, showing that a small number of participants developed antibodies to the virus after treatment.

A Phase 1 trial is a small trial of typically around 10 to 20 people that tests whether a potential new treatment is safe and whether it shows signs of its intended effects. Moderna has released the results of the first 8 participants whose data has been analyzed, and they show that the vaccine appears to be safe and not have any serious negative effects.

Read more
The FDA has shut down a Bill Gates-backed coronavirus testing program
Bill Gates

The Food and Drug Administration (FDA) halted, at least temporarily, a Seattle-based at-home coronavirus testing program backed by Bill Gates.

“Please discontinue patient testing and return of diagnostic results to patients until proper authorization is obtained,” the FDA told the Seattle Coronavirus Assessment Network (SCAN) in a memo, according to The New York Times.

Read more
The FBI accuses China of trying to steal U.S. coronavirus vaccine research
coronavirus taiwan asia technology success science researcher getty

The FBI and the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency have accused China of attempting to steal coronavirus vaccine research from the U.S.

“The FBI is investigating the targeting and compromise of U.S. organizations conducting COVID-19-related research by PRC-affiliated cyber actors and non-traditional collectors,” according to a joint announcement Wednesday.

Read more